Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06599996 · ClinicalTrials.gov registry record · NA
Artificial Intelligence and Augmentative and Alternative Communication AAC
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT06599996 is a NA study that has completed, run by Penn State University. The registered enrollment target is 6 participants.
The verdict
NCT06599996, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The overarching objective of this project is to transform access to assistive communication technologies (augmentative and alternative communication) for individuals with motor disabilities and/or visual impairment, for whom natural speech is not meeting their communicative needs. These individuals often cannot access traditional augmentative and alternative communication because of their restricted movement or visual function. However, most such individuals have idiosyncratic body-based means of communication that is reliably interpreted by familiar communication partners. The project will test artificial intelligence algorithms that gather information from sensors or camera feeds about these idiosyncratic movement patterns of the individual with motor/visual impairments. Based on the sensor or camera feed information, the artificial intelligence algorithms will interpret the individual's gestures and translate the interpretation into speech output. For instance, if an individual waves their hand as their means of communicating "I want", the artificial intelligence algorithm will detect that gesture and prompt the speech-generating technology to produce the spoken message "I want." This will allow individuals with restricted but idiosyncratic movements to access the augmentative and alternative communication technologies that are otherwise out of reach.
Interventions
- DEVICE Testing artificial intelligence algorithms for interpreting gestures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2024-09-24 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06599996
The ClinicalTrials.gov registry entry for NCT06599996 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testing artificial intelligence algorithms for interpreting gestures is the first listed.
NCT06599996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06599996 about?
NCT06599996 is a clinical study titled "Artificial Intelligence and Augmentative and Alternative Communication AAC". The overarching objective of this project is to transform access to assistive communication technologies (augmentative and alternative communication) for individuals with motor disabilities and/or visual impairment, for whom natural speech is not meeting their communicative needs. These individuals ...
What is the current status of trial NCT06599996?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2024-09-24. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT06599996?
The interventions under investigation include: Testing artificial intelligence algorithms for interpreting gestures (DEVICE).
Who is sponsoring clinical trial NCT06599996?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.